| Next revision | Previous revision |
| propranolol [2017/05/17 03:13] – created Scott Larson | propranolol [2025/04/18 20:40] (current) – external edit 127.0.0.1 |
|---|
| * US FDA pregnancy category C | * US FDA pregnancy category C |
| * Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant. | * Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant. |
| | * Beta blockers may cause decreased placental perfusion, fetal and neonatal bradycardia, and hypoglycemia. Propranolol has been used safely to treat a variety of conditions during pregnancy, including hypertension and pheochromocytoma in the mother, and tachyarrhythmias in both the mother and fetus. There are a number of abnormalities associated with the use of propranolol during pregnancy, but many of these may be attributable to underlying diseases. These abnormalities include some signs of beta-blockade, such as bradycardia, hypoglycemia, and respiratory depression. Other abnormalities that may be due to propranolol include intrauterine growth retardation, small placentas, polycythemia, thrombocytopenia, and hypocalcemia |
| Beta blockers may cause decreased placental perfusion, fetal and neonatal bradycardia, and hypoglycemia. Propranolol has been used safely to treat a variety of conditions during pregnancy, including hypertension and pheochromocytoma in the mother, and tachyarrhythmias in both the mother and fetus. There are a number of abnormalities associated with the use of propranolol during pregnancy, but many of these may be attributable to underlying diseases. These abnormalities include some signs of beta-blockade, such as bradycardia, hypoglycemia, and respiratory depression. Other abnormalities that may be due to propranolol include intrauterine growth retardation, small placentas, polycythemia, thrombocytopenia, and hypocalcemia | |
| |
| * Excreted into human milk | * Excreted into human milk |
| * Some recommend monitoring infant for signs and symptoms of beta-brocade and schedule feeds at least 3 hours after maternal propranolol administration | * Some recommend monitoring infant for signs and symptoms of beta-brocade and schedule feeds at least 3 hours after maternal propranolol administration |
| | |
| | ====== References ====== |
| | [[https://www.drugs.com/pro/propranolol.html|Drugs.com]] |
| | |
| | {{tag>drugs}} |